PathAI and Labcorp Broaden Strategic Collaboration to Accele

PathAI and Labcorp Broaden Strategic Collaboration to Accelerate Use of AI-Powered Pathology


PathAI and Labcorp Broaden Strategic Collaboration to Accelerate Use of AI-Powered Pathology
Share Article
BOSTON and BURLINGTON, N.C. (PRWEB)
March 08, 2021
PathAI, a global provider of artificial intelligence-powered (AI-powered) technology for use in pathology research, and Labcorp (NYSE: LH), a leading global life sciences company, today announced the broadening of their strategic partnership in the field of AI-powered pathology. The collaboration builds on Labcorp’s past investment in PathAI and the companies’ collaboration on a series of projects, including the deployment of PathAI algorithms in clinical trials managed by Labcorp Drug Development.
A key focus of the expanded collaboration will be to enable, in prospective clinical trials of cancer and other diseases, the seamless deployment of PathAI’s algorithms in the broad portfolio of programs managed by Labcorp Drug Development. These PathAI algorithms are developed using Good Clinical Laboratory Practice (GCLP) guidelines and process controls and are locked and validated as fit for purpose; they can also be further extended to companion diagnostic (CDx) device development and commercialization. They can be deployed in retrospective or prospective clinical trials to quantify tissue-based biomarkers and can support patient stratification and selection. The algorithms have many potential additional uses where robust deployment and data collection are needed. Labcorp and PathAI plan to explore bridging the use of AI-powered algorithms from translational research into a clinical laboratory setting.

Related Keywords

Burlington , Massachusetts , United States , Boston , Paul Kirchgraber , Randy Beck , Linkedin , Labcorp Drug Development , Covance , Labcorp The Company , Good Clinical Laboratory Practice , Labcorp Drug , Annual Report , Press Release , பர்லிங்டன் , மாசசூசெட்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , போஸ்டன் , ஆண்டி பெக் , சென்டர் , லாப்கோர்ப் மருந்து வளர்ச்சி , லாப்கோர்ப் தி நிறுவனம் , நல்ல மருத்துவ ஆய்வகம் ப்ர்யாக்டீஸ் , லாப்கோர்ப் மருந்து , ஆண்டு அறிக்கை , ப்ரெஸ் வெளியீடு ,

© 2025 Vimarsana